BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.52 EUR | -0.44% |
|
-1.61% | -15.28% |
| 02:18pm | IQ-AI Unit Delivers Software to Insel Gruppe | MT |
| 12:50pm | Bayer: elinzanetant data presented at congress | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.65
EUR
Average target price
36.9
EUR
Spread / Average Target
+28.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.28% | 30.59B | |
| +32.02% | 694B | |
| +29.64% | 593B | |
| -1.74% | 371B | |
| +19.59% | 331B | |
| +6.33% | 290B | |
| +14.26% | 239B | |
| -3.31% | 209B | |
| +9.91% | 209B | |
| +8.37% | 169B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies